oxyphenbutazone has been researched along with Dysphagia in 2 studies
Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miotti, R | 1 |
| Vandehove, P | 1 |
| Vande Weghe, JP | 1 |
| Boedts, D | 1 |
1 trial available for oxyphenbutazone and Dysphagia
| Article | Year |
|---|---|
[Study of the effect of oxyphenbutazone on the radiation reaction in cobalt isotope teletherapy of neoplasms in a double blind experiment].
Topics: Clinical Trials as Topic; Cobalt Isotopes; Deglutition Disorders; Esophageal Neoplasms; Humans; Neop | 1969 |
1 other study available for oxyphenbutazone and Dysphagia
| Article | Year |
|---|---|
Observations on the use of benzydamine hydrochloride in otorhinolaryngology.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Cicatrix; Deglutition Disorders; | 1968 |